These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32516030)

  • 1. The Role of Opioids and Their Receptors in Urological Malignancy: A Review.
    Lec PM; Lenis AT; Golla V; Brisbane W; Shuch B; Garraway IP; Reiter RE; Chamie K
    J Urol; 2020 Dec; 204(6):1150-1159. PubMed ID: 32516030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and cancer prognosis: A summary of the clinical evidence.
    Ramirez MF; Gorur A; Cata JP
    Neurosci Lett; 2021 Feb; 746():135661. PubMed ID: 33482308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and Cancer Mortality.
    Amaram-Davila J; Davis M; Reddy A
    Curr Treat Options Oncol; 2020 Feb; 21(3):22. PubMed ID: 32095929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids increase bladder cancer cell migration via bradykinin B2 receptors.
    Vassou D; Notas G; Hatzoglou A; Castanas E; Kampa M
    Int J Oncol; 2011 Sep; 39(3):697-707. PubMed ID: 21643624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative opioids are associated with improved recurrence-free survival in triple-negative breast cancer.
    Montagna G; Gupta HV; Hannum M; Tan KS; Lee J; Scarpa JR; Plitas G; Irie T; McCormick PJ; Fischer GW; Morrow M; Mincer JS
    Br J Anaesth; 2021 Feb; 126(2):367-376. PubMed ID: 33220939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review.
    Nijland L; Schmidt P; Frosch M; Wager J; Hübner-Möhler B; Drake R; Zernikow B
    Support Care Cancer; 2019 Jan; 27(1):33-42. PubMed ID: 30056529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review.
    Lefkowits C; Buss MK; Ramzan AA; Fischer S; Urban RR; Fisher CM; Duska LR
    Gynecol Oncol; 2018 May; 149(2):394-400. PubMed ID: 29472016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Tumour Recurrence in Patients Undergoing Renal Transplantation for End-stage Renal Disease after Previous Treatment for a Urological Cancer: A Systematic Review.
    Boissier R; Hevia V; Bruins HM; Budde K; Figueiredo A; Lledó-García E; Olsburgh J; Regele H; Taylor CF; Zakri RH; Yuan CY; Breda A
    Eur Urol; 2018 Jan; 73(1):94-108. PubMed ID: 28803033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioids and cancer: friend or foe?
    Wigmore T; Farquhar-Smith P
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):109-18. PubMed ID: 26990052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility.
    Ramzan AA; Fischer S; Buss MK; Urban RR; Patsner B; Duska LR; Fisher CM; Lefkowits C
    Gynecol Oncol; 2018 May; 149(2):401-409. PubMed ID: 29544707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of opioid utility in cancer pain populations.
    Wong SS; Cheung CW
    Ann Palliat Med; 2020 Mar; 9(2):558-570. PubMed ID: 32233627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid requirement, opioid receptor expression, and clinical outcomes in patients with advanced prostate cancer.
    Zylla D; Gourley BL; Vang D; Jackson S; Boatman S; Lindgren B; Kuskowski MA; Le C; Gupta K; Gupta P
    Cancer; 2013 Dec; 119(23):4103-10. PubMed ID: 24104703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioids and tumour metastasis: does the choice of the anesthetic-analgesic technique influence outcome after cancer surgery?
    Connolly C; Buggy DJ
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):468-74. PubMed ID: 27214644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target.
    Chen DT; Pan JH; Chen YH; Xing W; Yan Y; Yuan YF; Zeng WA
    Br J Anaesth; 2019 Jun; 122(6):e157-e167. PubMed ID: 30915986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids: old drugs for potential new applications.
    Barry U; Zuo Z
    Curr Pharm Des; 2005; 11(10):1343-50. PubMed ID: 15853689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation.
    Carli M; Donnini S; Pellegrini C; Coppi E; Bocci G
    Pharmacol Res; 2020 Sep; 159():104938. PubMed ID: 32504831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urologic malignancies in renal transplant candidates and recipients].
    Kleinclauss F; Thuret R; Murez T; Timsit MO
    Prog Urol; 2016 Nov; 26(15):1094-1113. PubMed ID: 27665407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor subtypes involved in the central inhibition of urinary bladder motility.
    Dray A; Metsch R
    Eur J Pharmacol; 1984 Sep; 104(1-2):47-53. PubMed ID: 6094211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane Reviews.
    Els C; Jackson TD; Kunyk D; Lappi VG; Sonnenberg B; Hagtvedt R; Sharma S; Kolahdooz F; Straube S
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012509. PubMed ID: 29084357
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.